scholarly journals Efficacy and Safety of Oral Lactoferrin Supplementation in Combination with rHuEPO‐β for the Treatment of Anemia in Advanced Cancer Patients Undergoing Chemotherapy: Open‐Label, Randomized Controlled Study

2010 ◽  
Vol 15 (8) ◽  
pp. 894-902 ◽  
Author(s):  
Antonio Macciò ◽  
Clelia Madeddu ◽  
Giulia Gramignano ◽  
Carlo Mulas ◽  
Eleonora Sanna ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Advanced Cancer Patients ◽  
Open Label ◽  
Randomized Controlled

Advanced cancer patients’ reported priorities regarding wishes at the end of life: A randomized controlled study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 9546-9546
Author(s):  
Marvin Omar Delgado-Guay ◽  
Vera J De la Cruz ◽  
Susan Frisbee-Hume ◽  
Janet L. Williams ◽  
Jimin Wu ◽  
...  
Keyword(s):  
End Of Life ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Advanced Cancer Patients ◽  
Randomized Controlled

Efficacy and safety of modafinil versus dexamethasone in cancer-related fatigue: a prospective randomized controlled study

2021 ◽  
Author(s):  
Uttiya Deb ◽  
Sandip Mukhopadhyay ◽  
Biswamit Bhattacharya ◽  
Sanatan Banerjee ◽  
Supreeti Biswas
Keyword(s):  
Cancer Patients ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Randomized Controlled ◽  
Cancer Related Fatigue ◽  
Severe Fatigue ◽  
Curative Radiotherapy ◽  
Clinical Trials Registry

The aim of this study was to compare the efficacy and safety of modafinil and dexamethasone in the management of cancer-related fatigue and their effects on quality of life (QoL). A prospective randomized controlled study was conducted, enrolling 80 cancer patients experiencing moderate or severe fatigue following at least three cycles of chemotherapy or a course of palliative/curative radiotherapy. Patients received either oral modafinil 100 mg or dexamethasone 4 mg daily for 14 days. Levels of fatigue, QoL and symptom severity were compared after 14–21 days. Both drugs were efficacious and safe in the management of fatigue and QoL. However, modafinil performed marginally better. Although modafinil demonstrated marginal superiority, both modafinil and dexamethasone can improve fatigue and QoL in cancer patients. Clinical trials registry of India: CTRI/2018/05/014046 (www.ctri.nic.in)

Efficacy and Safety of Insulin Degludec and Insulin Glargine U-100 in Hospitalized Patients with Type 2 Diabetes—An Open-Label, Randomized Controlled Study

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 302-OR
Author(s):  
JUN SUZUKI ◽  
TADASHI YAMAKAWA ◽  
MINORI SHINODA ◽  
RIKA SAKAMOTO ◽  
KENICHIRO TAKAHASHI ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Degludec ◽  
Hospitalized Patients ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Randomized Controlled

Efficacy and Safety of Sofosbuvir/Daclatasvir in the Treatment of COVID-19: A Randomized, Controlled Study

2020 ◽  
Author(s):  
Mostafa Yakoot ◽  
Basem Eysa ◽  
Essam Gouda ◽  
Andrew Hill ◽  
Sherine A. Helmy ◽  
...  
Keyword(s):  
Randomized Controlled Study ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document